Markets · 1 sources covering this

Beyond Jio IPO: 5 triggers Mukesh Ambani has lined up to revive Reliance shares for 44 lakh investors

Reliance Industries is charting a new course to boost its stock for 44 lakh investors, moving beyond a potential Jio IPO. Billionaire Mukesh Ambani has unveiled five key growth drivers, including revitalizing the O2C business, scaling up new energy ventures, building India's AI backbone, expanding FMCG operations to a Rs 1 lakh crore target, and becoming a major export hub.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

Economic TimesLean R·3h ago
Beyond Jio IPO: 5 triggers Mukesh Ambani has lined up to revive Reliance shares for 44 lakh investors
Reliance Industries is charting a new course to boost its stock for 44 lakh investors, moving beyond a potential Jio IPO. Billionaire Mukesh Ambani has unveiled five key growth drivers, including revitalizing the O2C business, scaling up new energy ventures, building India's AI backbone, expanding FMCG operations to a Rs 1 lakh crore target, and becoming a major export hub.
Read at Economic Times →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/839cbfb837ba4425438282d34c6e2b5f613d5367"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Beyond Jio IPO: 5 triggers Mukesh Ambani has lined up to revive Reliance shares for 44 lakh investors"></iframe>

Beyond Jio IPO: 5 triggers Mukesh Ambani has lined up to revive Reliance shares for 44 lakh investors

How 1 sources are covering this

Beyond Jio IPO: 5 triggers Mukesh Ambani has lined up to revive Reliance shares for 44 lakh investors

More from Markets

US bond yields back to 'normal'; AI needs a reality check, says Ed Yardeni

Will AI talent departures hurt Alphabet's long-term growth?

Kirloskar Oil Engines shares up 36% in 2 days. Should you buy or sell?

Avience Biomedicals IPO share allotment in focus today; GMP, steps to check status online

Reader

Trust & legal

Across the network